3 directorsName hiddenVisible after signing in and 2 others
Owners2 names in the annual accounts
consolidatesHidden nameVisible after signing in
Documentsfilings and deeds
27-06-202234 days before the deadline
2021financial year
Staff from 28 FTE to 24 FTEName after signing inVisible after signing in resigns as director10-12Registered office moved from Braine-l'Alleud to Watermael-Boi…15-10Hidden nameVisible after signing in appointed as statutory auditor19-08Registered office moved to Brussels15-07Equity from €27.5m to €32.2m
Key points
from the 2021 annual accounts, the last ones filed
Merger proposal: to be absorbed by Bristol-Myers Squibb BelgiumName hiddenVisible after signing in. holds all the shares · Gazette deed
Resignations & appointmentsHidden nameVisible after signing in holds all the shares · Gazette deed
1 director appointed, 2 resignationsName after signing inVisible after signing in and Name hiddenVisible after signing in resign · Hidden nameVisible after signing in appointed · General meeting of 01-12-2021 · Gazette deed
“La recherche et le développement, les tests cliniques, la distribution, la vente, l'achat, l'import…” (deed in French)From the articles, 3 activitiesNo NACE code in the KBO
Joint committee
207White-collar workers in the chemical industry · annual accounts 2021